Maternal serum marker medians in Aboriginal Canadian women

Prenatal Diagnosis

Volumn 23, Issue 2, 2003, Pages 98-100

  Huang, Tianhua ^a   Summers, Anne M ^a   Wyatt, Philip R ^a   Meier, Chris ^a   Côté, Gilbert B ^b  

^a NORTH YORK GENERAL HOSPITAL   (Canada)

^b SUDBURY REGIONAL HOSPITAL   (Canada)

Author keywords

Aboriginal women; Alpha fetoprotein; Down syndrome; Serum screening; Unconjugated estriol and total human chorionic gonadotrophin

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ABORIGINE; ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; PARITY; PRIORITY JOURNAL; SCREENING; TRISOMY 18;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CANADA; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; REFERENCE VALUES;

EID: 0037330206     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.537     Document Type: Article

References (18)

1. Benn PA, Clive JM, Collins R. 1997. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem 43(2): 333-337.
2. Chodirker BN, Erdile LB, MacDonald KM, Harman CR, Cheang MS, Evans JA. 1994. MSAFP levels in aboriginal Canadian women. Can J Pub Health 85(6): 424-426.
3. Crandall BF, Lebherz TB, Schroth PC, Matsumoto M. 1983. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight. Clin Chem 29(3): 531-533.
4. Crossley JA, Berry E, Aitken DA, Connor JM. 1996. Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme. Prenat Diagn 16(11): 1039-1042.
5. Kramer RL, Yaron Y, O'Brien JE, et al. 1998. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus. Am J Med Genet 75(2): 176-178.
6. Kulch P, Keener S, Matsumoto M, Crandall BF. 1993. Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels. Prenat Diagn 13(3): 191-195.
7. Kvale K, Glysch RL, Gothard M, Aakko E, Remington P. 2000. Trends in smoking during pregnancy, Wisconsin 1990 to 1996. WMJ 99(2): 63-67.
8. Lavallee C, Bourgault C. 2000. The health of Cree, Inuit and southern Quebec women: similarities and differences. Can J Pub Health 91(3): 212-216.
9. Mathews TJ. 1998. Smoking during pregnancy, 1990-96. Natl Vital Stat Rep 47(10): 1-12.
10. Muhajarine N, D'Arcy C, Edouard L. 1997. Prevalence and predictors of health risk behaviours during early pregnancy: Saskatoon Pregnancy and Health Study. Can J Pub Health 88(6): 375-379.
11. O'Brien JE, Dvorin E, Drugan A, Johnson MP, Yaron Y, Evans MI. 1997. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstet Gynecol 89(3): 355-358.
12. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. 1993. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Obstet Gynecol 81(5(Ptl)): 675-678.
13. Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. 1992. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 99(2): 144-149.
14. Wald NJ, Densem JW, Cheng R, Collishaw S. 1994. Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome. Prenat Diagn 14(9): 835-837.
15. Wald NJ, Watt HC. 1996. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Prenat Diagn 16(8): 699-703.
16. Watt HC, Wald NJ, Smith D, Kennard A, Densem J. 1996. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Prenat Diagn 16(8): 691-698.
17. Watt HC, Wald NJ. 1998. Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defects. Prenat Diagn 18(8): 842-845.
18. Wenstrom KD, Owen J, Boots L, Ethier M. 1995. The influence of maternal weight on human chorionic gonadotropin in the multiple-marker screening test for fetal Down syndrome. Am J Obstet Gynecol 173(4): 1297-1300.